scholarly article | Q13442814 |
P50 | author | Anne B. Newman | Q21401975 |
Bruce M. Psaty | Q30429993 | ||
Chino S Aneke-Nash | Q117248710 | ||
Anne Cappola | Q88050382 | ||
Lewis Kuller | Q88077314 | ||
Howard D Strickler | Q89146137 | ||
Jorge R Kizer | Q90008021 | ||
P2093 | author name string | Robert C Kaplan | |
Michael Pollak | |||
Thomas Rohan | |||
Christopher I Li | |||
Garrett Strizich | |||
Petra Bužková | |||
Clara Dominguez-Islas | |||
P2860 | cites work | GH and the cardiovascular system: an update on a topic at heart | Q27002329 |
Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human | Q28273575 | ||
The Cardiovascular Health Study: design and rationale | Q29614874 | ||
The role of ghrelin in GH secretion and GH disorders | Q30410009 | ||
Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations | Q33648509 | ||
Do changes in circulating biomarkers track with each other and with functional changes in older adults? | Q33684577 | ||
Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. | Q33973327 | ||
Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. | Q34408943 | ||
Ghrelin: much more than a natural growth hormone secretagogue | Q34787341 | ||
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin | Q35794412 | ||
Molecular interactions of the IGF system | Q36152450 | ||
Insulin-like growth factor axis and risk of type 2 diabetes in women | Q36182551 | ||
Cachexia: pathophysiology and clinical relevance | Q36442937 | ||
Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studies | Q36494391 | ||
Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study | Q36784395 | ||
Handling missing data in survey research | Q36833927 | ||
Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample | Q36834958 | ||
Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits | Q37235560 | ||
Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study | Q37408256 | ||
Total and cause-specific mortality in the cardiovascular health study | Q37413113 | ||
IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis | Q37435220 | ||
Ghrelin and bone | Q38117311 | ||
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study | Q38487837 | ||
Insulin-like growth factor binding protein-1: recent findings and new directions. | Q41663650 | ||
Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study | Q43427739 | ||
Post-prandial decrease of circulating human ghrelin levels | Q43659734 | ||
Effect of age and frailty on ghrelin and cholecystokinin responses to a meal test | Q48288737 | ||
Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke. | Q48783816 | ||
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke | Q48797065 | ||
Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. | Q51452772 | ||
Gender differences in the insulin-like growth factor axis response to a glucose load. | Q51496437 | ||
Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. | Q53099399 | ||
Insulin-like growth factor-binding protein-1 modulates blood glucose levels | Q67700946 | ||
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study | Q70785076 | ||
Laboratory methods and quality assurance in the Cardiovascular Health Study | Q72588345 | ||
Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women | Q73639535 | ||
Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke | Q79691420 | ||
Circulating ghrelin levels in obese women: a possible association with hypertension | Q80973643 | ||
Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study | Q81727199 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 267-278 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort | |
P478 | volume | 102 |
Q91785667 | Ghrelin regulates sepsis‑induced rat acute gastric injury |
Q57030354 | Sex-specific correlation of IGFBP-2 and IGFBP-3 with vitamin D status in adults with obesity: a cross-sectional serum proteomics study |
Q47639338 | The Association Between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study |
Q39433153 | The Role of Ghrelin and Ghrelin Signaling in Aging |
Q47866435 | Trajectories of IGF-I Predict Mortality in Older Adults: The Cardiovascular Health Study |
Search more.